NOBIVAC® Feline 2-FeLV | Merck Animal Health USA
WEBIndications: Shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline leukemia viruses. Duration of immunity is at least 2 years. Also shown to be effective against persistent viremia in cats exposed to virulent feline leukemia virus.
Nobivac Feline 2-FeLV for Animal Use - Drugs.com
WEBAug 26, 2024 · Nobivac Feline 2-FeLV Indications. This product has been shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline leukemia viruses. Duration of Immunity is at least 2 years. To review efficacy and safety data, go to productdata.aphis.usda.gov.
Nobivac® NXT FeLV | Merck Animal Health USA
WEBUncompromising Safety and Efficacy. NOBIVAC® NXT FeLV outperforms PUREVAX® FeLV1. NOBIVAC® NXT FeLV prevents FeLV from persisting in the bloodstream. NOBIVAC® NXT FeLV is the only non-adjuvanted FeLV vaccine with a 2-year duration of immunity (DOI) Nobivac® NXT FeLV is proven safe for kittens as young as 8 …
New vaccine protects against feline leukemia virus - dvm360
WEB19 hours ago · Merck Animal Health announced the expansion of the recently USDA-approved NOBIVAC NXT vaccination platform to include a solution against feline leukemia virus (FeLV)—one of the most common feline infectious diseases. 1 NOBIVAC NXT FeLV is a nonadjuvanted, low volume 0.5 mL dose vaccination that uses the immune system’s natural strengths to preserve comfort and safety. 1,2 The vaccine is ...
MSD Animal Health's Ground-breaking FeLV Vaccine
WEB1 day ago · The NOBIVAC NXT FeLV vaccine is labeled effective against persistent viremia and is indicated for the vaccination of cats 8 weeks of age or older against FeLV. According to the label and recommendations from the American Association of Feline Practitioners (AAFP), the vaccine should be administered in 2 doses, 3- to 4-weeks apart.
Nobivac® Feline 2-FeLV - Animal Health USA
WEBVaccination with this product prevents persistent viremia in cats exposed to virulent feline leukemia virus. DOSAGE AND ADMINISTRATION: Prior to use, warm the Nobivac Feline 2-FeLV to room temperature and shake well.
Nobivac® FeLV, suspension for injection for cats
WEBIndications for use. − For active immunisation of healthy cats to prevent persistent feline leukaemia-virus viraemia and any associated clinical signs of the feline leucosis. − The onset of protection begins 2 weeks after immunisation and the duration of protection lasts one year after the primo-vaccination.
Comparative Efficacy of Feline Leukemia Virus (FeLV ... - PubMed
WEBThe results demonstrate that Nobivac feline 2-FeLV-vaccinated cats were fully protected against persistent antigenemia and had significantly smaller amounts of proviral DNA and plasma viral RNA loads than PureVax recombinant FeLV-vaccinated cats …
Nobivac® FeLV, suspension for injection for cats - NOAH …
WEBSpecies: Cats. Therapeutic indication: Immunological veterinary medical products: For cats. Active ingredient: Vaccine Antigens. Product: Nobivac® FeLV, suspension for injection for cats. Product index: Nobivac® FeLV. Incorporating: Next. Connect with us.
Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated …
WEBJun 23, 2015 · Nobivac feline 2-FeLV had a demonstrated vaccine efficacy of 100% (prevented fraction) compared to the control group. The prevented fraction for the PureVax recombinant FeLV group was calculated at 45% compared to the control group.
- Some results have been removed